RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
+22.15%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.76B
AUM Growth
+$164M
(+6.3%)
Cap. Flow
-$52M
Cap. Flow
% of AUM
-1.88%
Top 10 Holdings %
Top 10 Hldgs %
29.44%
Holding
155
New
8
Increased
52
Reduced
20
Closed
10
Top Buys
| 1 |
Boston Scientific
BSX
|
$24.2M |
| 2 |
ALLK
Allakos
ALLK
|
$18.2M |
| 3 |
Encompass Health
EHC
|
$17.7M |
| 4 |
Elanco Animal Health
ELAN
|
$13.1M |
| 5 |
Zimmer Biomet
ZBH
|
$8.41M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$26.8M |
| 2 |
AbbVie
ABBV
|
$26M |
| 3 |
Gilead Sciences
GILD
|
$25.9M |
| 4 |
Acadia Healthcare
ACHC
|
$19.5M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
$19.4M |
Sector Composition
| 1 | Healthcare | 89.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
AbbVie
ABBV
$375B
| $30.7M | 1.11% |
325,000
-275,000
| -46% | -$26M |
|
27
Exact Sciences
EXAS
$10.2B
| $30.4M | 1.1% |
385,000
+5,000
| +1% | +$395K |
|
|
28
Zimmer Biomet
ZBH
$20.9B
| $29.6M | 1.07% |
231,750
+65,920
| +40% | +$8.41M |
|
|
ONCE
29
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $29.3M | 1.06% |
537,500
-6,500
| -1% | -$355K |
|
30
DaVita
DVA
$9.86B
| $29.3M | 1.06% |
408,500
| – | – |
|
|
WMGI
31
DELISTED
Wright Medical Group Inc
WMGI
| $29M | 1.05% |
1,000,000
| – | – |
|
|
TSRO
32
DELISTED
TESARO, Inc.
TSRO
| $28.7M | 1.04% |
735,000
+109,600
| +18% | +$4.28M |
|
|
ALDR
33
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $27.2M | 0.98% |
1,632,500
+67,500
| +4% | +$1.12M |
|
34
Align Technology
ALGN
$10.1B
| $26.4M | 0.96% |
67,500
+1,500
| +2% | +$587K |
|
|
35
Acadia Healthcare
ACHC
$2.19B
| $24.6M | 0.89% |
700,000
-553,500
| -44% | -$19.5M |
|
36
Incyte
INCY
$16.9B
| $24.3M | 0.88% |
352,100
+56,100
| +19% | +$3.88M |
|
37
Collegium Pharmaceutical
COLL
$1.21B
| $24.3M | 0.88% |
1,650,100
+100
| +0% | +$1.47K |
|
38
Thermo Fisher Scientific
TMO
$186B
| $23.4M | 0.85% |
96,000
| – | – |
|
|
NVTA
39
DELISTED
Invitae Corporation
NVTA
| $23.4M | 0.85% |
1,400,000
| – | – |
|
40
Baxter International
BAX
$12.5B
| $22.9M | 0.83% |
297,000
| – | – |
|
|
RDUS
41
DELISTED
Radius Health, Inc.
RDUS
| $22.6M | 0.82% |
1,267,500
+142,500
| +13% | +$2.54M |
|
42
Puma Biotechnology
PBYI
$253M
| $22.4M | 0.81% |
487,600
+11,800
| +2% | +$541K |
|
43
Idexx Laboratories
IDXX
$51.4B
| $20.8M | 0.75% |
83,500
+11,500
| +16% | +$2.87M |
|
|
MDCO
44
DELISTED
Medicines Co
MDCO
| $20.6M | 0.75% |
690,000
| – | – |
|
|
OBSV
45
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $20.2M | 0.73% |
1,120,000
| – | – |
|
46
Axogen
AXGN
$735M
| $20M | 0.73% |
543,474
-1,526
| -0.3% | -$56.2K |
|
47
Galapagos
GLPG
$2.2B
| $20M | 0.72% |
177,500
-7,500
| -4% | -$843K |
|
48
West Pharmaceutical
WST
$18B
| $19.8M | 0.72% |
160,000
| – | – |
|
49
FibroGen
FGEN
$48.9M
| $18.6M | 0.67% |
12,240
-40
| -0.3% | -$60.8K |
|
|
ALLK
50
DELISTED
Allakos
ALLK
| $18.2M | 0.66% |
+405,000
| New | +$18.2M |
|